Healthy Male

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GC Biopharma
GC BiopharmaKorea - Yongin
1 program
1
GCC-4401Phase 11 trial
Active Trials
NCT01651234CompletedEst. Aug 2012
I
IdienceCA - San Francisco
1 program
1
IDX-1197Phase 11 trial
Active Trials
NCT05202912CompletedEst. Jul 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IdienceIDX-1197
GC BiopharmaGCC-4401

Clinical Trials (2)

NCT05202912IdienceIDX-1197

Food Effect Study of IDX-1197 in Healthy Subjects

Start: Jan 2022Est. completion: Jul 2022
Phase 1Completed
NCT01651234GC BiopharmaGCC-4401

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

Start: Mar 2012Est. completion: Aug 2012
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space